Oscar W.
- Country
- Sweden
- Department
- Breast Center
Research Overview
- Phase 1/2a Study of BI-1206 and Pembrolizumab in Advanced Solid Tumors Post Anti-PD-1/PD-L1 Therapy
- Therapeutic Dose Monitoring of Epirubicin, Cyclophosphamide, Docetaxel, Paclitaxel, and Doxorubicin in Female Breast Cancer Patients
- Evaluation of [68Ga]Ga-ABY-025 PET Imaging for HER2 Expression and Predictive Value of Trastuzumab Deruxtecan in Metastatic Breast Cancer
Data & Insights
Has run more than one trial at 13 of 35 partner sites.
Specializations
Oncology Focus
This investigator specializes in multiple areas of oncology treatment, with particular emphasis on breast cancer and prostate cancer therapeutics.
- Advanced metastatic breast cancer management
- Castration-resistant prostate cancer treatment
- Non-small cell lung cancer therapy
- Colorectal cancer interventions
The investigator has notable expertise in HER2-positive breast cancer treatments and novel therapeutic approaches for various cancer types.
Cardiovascular Medicine
The investigator demonstrates significant involvement in cardiovascular health research, focusing on various cardiac conditions.
- Atrial fibrillation management
- Chronic heart failure treatment
- Abdominal aortic aneurysm therapy
- Dyslipidemia interventions
Their work includes innovative approaches to cardiac condition management and preventive cardiology.
Metabolic and Renal Disorders
The investigator shows dedicated focus on metabolic disorders and kidney disease treatment, particularly in specialized populations.
- Type 2 diabetes management
- Chronic kidney disease treatment
- Proteinuria interventions
- Alcohol-related liver disease therapy
Their expertise extends to both adult and pediatric renal conditions with emphasis on innovative therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.